Your browser doesn't support javascript.
loading
Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia.
Heltemes-Harris, Lynn M; Willette, Mark J L; Ramsey, Laura B; Qiu, Yi Hua; Neeley, E Shannon; Zhang, Nianxiang; Thomas, Deborah A; Koeuth, Thearith; Baechler, Emily C; Kornblau, Steven M; Farrar, Michael A.
Afiliação
  • Heltemes-Harris LM; Department of Laboratory Medicine and Pathology, The Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
J Exp Med ; 208(6): 1135-49, 2011 Jun 06.
Article em En | MEDLINE | ID: mdl-21606506
ABSTRACT
As STAT5 is critical for the differentiation, proliferation, and survival of progenitor B cells, this transcription factor may play a role in acute lymphoblastic leukemia (ALL). Here, we show increased expression of activated signal transducer and activator of transcription 5 (STAT5), which is correlated with poor prognosis, in ALL patient cells. Mutations in EBF1 and PAX5, genes critical for B cell development have also been identified in human ALL. To determine whether mutations in Ebf1 or Pax5 synergize with STAT5 activation to induce ALL, we crossed mice expressing a constitutively active form of STAT5 (Stat5b-CA) with mice heterozygous for Ebf1 or Pax5. Haploinsufficiency of either Pax5 or Ebf1 synergized with Stat5b-CA to rapidly induce ALL in 100% of the mice. The leukemic cells displayed reduced expression of both Pax5 and Ebf1, but this had little effect on most EBF1 or PAX5 target genes. Only a subset of target genes was deregulated; this subset included a large percentage of potential tumor suppressor genes and oncogenes. Further, most of these genes appear to be jointly regulated by both EBF1 and PAX5. Our findings suggest a model whereby small perturbations in a self-reinforcing network of transcription factors critical for B cell development, specifically PAX5 and EBF1, cooperate with STAT5 activation to initiate ALL.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação Leucêmica da Expressão Gênica / Transativadores / Fator de Transcrição STAT5 / Fator de Transcrição PAX5 / Mutação Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Exp Med Ano de publicação: 2011 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação Leucêmica da Expressão Gênica / Transativadores / Fator de Transcrição STAT5 / Fator de Transcrição PAX5 / Mutação Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Exp Med Ano de publicação: 2011 Tipo de documento: Article País de afiliação: Estados Unidos